Treatment - therapeutic lifestyle modification.

[1]  Y. Matsuzawa.  The metabolic syndrome and adipocytokines , 2006, FEBS letters.

[2]  S. Yusuf,et al.  Homocysteine lowering with folic acid and B vitamins in vascular disease. , 2006, The New England journal of medicine.

[3]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[4]  Y. Kokubo,et al.  Intake of Fish and n3 Fatty Acids and Risk of Coronary Heart Disease Among Japanese: The Japan Public Health Center-Based (JPHC) Study Cohort I , 2006, Circulation.

[5]  S. Yusuf,et al.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.

[6]  A. Tamakoshi,et al.  Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study. , 2005, American journal of epidemiology.

[7]  David B Allison,et al.  Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. , 2004, Circulation.

[8]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[9]  H. Ueshima,et al.  Cigarette Smoking as a Risk Factor for Stroke Death in Japan NIPPON DATA80 , 2004, Stroke.

[10]  Jane B Shofer,et al.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. , 2004, Diabetes.

[11]  H. Ueshima,et al.  Non-pharmacological intervention study of hypercholesterolemia among middle-aged people , 2004, Environmental health and preventive medicine.

[12]  J. Hayashi,et al.  The influence of lifestyle modification on carotid artery intima-media thickness in a suburban Japanese population. , 2004, Atherosclerosis.

[13]  A. Tenenbaum,et al.  Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. , 2003, Archives of internal medicine.

[14]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[15]  Fernando Costa,et al.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph , 2003, Circulation.

[16]  E. Topol,et al.  Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials , 2003, The Lancet.

[17]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[18]  D. Heymann,et al.  Deadly comrades: war and infectious diseases , 2002, The Lancet.

[19]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[20]  Barbara E Ainsworth,et al.  Epidemiology of musculoskeletal injuries among sedentary and physically active adults. , 2002, Medicine and science in sports and exercise.

[21]  C. Schindler,et al.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. , 2002, The American journal of medicine.

[22]  N. Rigotti,et al.  T REATMENT OF T OBACCO U SE AND D EPENDENCE , 2002 .

[23]  A. Nissinen,et al.  Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. , 2000, European heart journal.

[24]  I. Piña,et al.  AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endo , 2000, Circulation.

[25]  L. Appel,et al.  Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. , 1999, JAMA.

[26]  A. Catapano,et al.  Antioxidants and coronary artery disease , 1999, Current atherosclerosis reports.

[27]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[28]  R. Krauss,et al.  Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1999, Circulation.

[29]  K. Gould,et al.  Intensive lifestyle changes for reversal of coronary heart disease. , 1998, JAMA.

[30]  P. Reaven,et al.  The role of dietary fatty acids in lipoprotein oxidation and atherosclerosis. , 1998, Current opinion in lipidology.

[31]  M. Malinow,et al.  Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. , 1998, The New England journal of medicine.

[32]  E. Bleecker,et al.  Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. , 1995, JAMA.

[33]  James W. Anderson,et al.  Meta-analysis of the effects of soy protein intake on serum lipids. , 1995, The New England journal of medicine.

[34]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[35]  P. Touboul,et al.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.

[36]  G. Watts,et al.  Nutrient intake and progression of coronary artery disease. , 1994, The American journal of cardiology.

[37]  T. Ishiko,et al.  Effect of training and detraining on in vivo insulin sensitivity. , 1990, International journal of sports medicine.

[38]  R. Kronmal,et al.  Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. , 1988, The New England journal of medicine.

[39]  K. Pennert,et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.

[40]  P. Björntorp,et al.  Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. , 1984, British medical journal.

[41]  I. Holme,et al.  EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men , 1981, The Lancet.

[42]  E. Rogot,et al.  Smoking and causes of death among U.S. veterans: 16 years of observation. , 1980, Public health reports.

[43]  G. Borg,et al.  Perceived exertion: a note on "history" and methods. , 1973, Medicine and science in sports.